Skip to content
Review Open access

Stimuli-Responsive Hydrogel Platforms for Precision Management of Diabetic Wounds: Integrating Controlled Drug Delivery, Biomarker Sensing, and Tissue Regeneration

Oct 2026 · International Journal of Drug Delivery Technology · 0 citations

Abstract

Background: Diabetic wounds represent a critical global health challenge, affecting over 40 million individuals worldwide. The complex pathophysiology-characterized by hyperglycemia, persistent inflammation, excessive oxidative stress, recurrent bacterial infection, and impaired angiogenesis-renders conventional wound dressings inadequate for effective management. Objective: This review critically evaluates recent advances in stimuli-responsive hydrogel platforms designed for precision management of diabetic wounds, with emphasis on systems integrating controlled drug delivery, realtime biomarker sensing, and tissue regeneration capabilities. Methods: A comprehensive literature review was conducted focusing on smart hydrogel systems responsive to glucose, pH, reactive oxygen species (ROS), temperature, and enzymes. Studies were categorized based on responsive mechanisms, therapeutic payloads, and preclinical efficacy outcomes. Results: Stimuli-responsive hydrogels demonstrate significant advantages over conventional dressings through their ability to sense microenvironmental changes and execute programmed therapeutic responses. Glucoseresponsive systems utilizing phenylboronic acid or glucose oxidase enable self-regulated insulin delivery. pHresponsive platforms exploit the acidic-to-alkaline transition in infected wounds for targeted antimicrobial release. ROS-scavenging hydrogels incorporating nanozymes or antioxidant polymers restore redox balance. Multiresponsive systems achieve synergistic therapeutic effects by integrating multiple sensing modalities. Nanohybrid architectures-incorporating metal nanoparticles, carbon-based nanomaterials, and metal-organic frameworksenhance mechanical properties and add multifunctional capabilities including real-time wound monitoring. Conclusion: Stimuli-responsive hydrogel platforms represent a paradigm shift in diabetic wound management, moving from passive coverage to active, intelligent intervention. Key challenges remain in clinical translation, including regulatory approval pathways, long-term biosafety validation, cost-effective manufacturing, and integration with point-of-care diagnostic technologies.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.